CNBC reporter Chloe Taylor writes that a study co-authored by MIT researchers examined Covid-19 antibody prevalence in Spain. The researchers found, “just 5% of participants presented with antibodies from point-of-care tests, while antibodies were detected in 4.6% of the blood samples.”
CNN reporter Allen Kim writes about how CSAIL researchers developed a new system that enables a robot to disinfect surfaces and neutralize aerosolized forms of the coronavirus. In the future, the researchers hope the robot could be used to enable autonomous UV disinfection “in other environments such as supermarkets, factories and restaurants.”
A study by MIT researchers finds that that the true number of Covid-19 related cases is likely 12 times higher than the official count, reports Jonathan Saltzman for The Boston Globe. The researchers found, “tougher policies to reduce transmission of the disease after WHO declared it a pandemic on March 11, along with extensive testing, could have prevented 197,000 deaths, nearly a third of the estimated fatalities.”
WHDH reporter Emily Pritchard spotlights how CSAIL researchers have developed a new robotic system that is being used to help disinfect the Greater Boston Food Bank during the coronavirus pandemic. “We believe that is one piece of the puzzle in figuring out how to mitigate the spread of coronavirus,” says research scientist Alyssa Pierson.
A new robotic system developed by CSAIL researchers uses UV-C light to kill viruses and bacteria on surfaces and aerosols, reports Darrell Etherington for TechCrunch. “Via cameras and sensors, the robot can map an indoor space, then navigate designed waypoints within that mapped area and disinfect as it goes, keeping track of the areas it has to disinfect,” writes Etherington.
MIT researchers have developed a new robotic system that uses a UV-C light fixture to disinfect surfaces at the Greater Boston Food Bank’s warehouse staging area, reports Matt Reed for WCVB. Research scientist Alyssa Pierson explains that the ultraviolet light "breaks apart the kind of outer incasing or shell of these pathogens."
MIT researchers have developed a skin patch that could be used to fight melanoma, reports Berkeley Lovelace Jr. for CNBC. “Our patch technology could be used to deliver vaccines to combat different infectious diseases,” explains Prof. Paula Hammond. “But we are excited by the possibility that the patch is another tool in the oncologists’ arsenal against cancer, specifically melanoma.”
A sensor developed by MIT researchers could make diagnosing sepsis easier, quicker and more affordable, reports Darrell Etherington for TechCrunch. Etherington explains that the sensor, which “employs microfluidics to detect the presence of key proteins in the blood,” could have “a huge potential impact, as sepsis is one of the leading causes of death in hospitals.”
The Singapore-MIT Alliance for Research and Technology (SMART) has launched an initiative aimed at advancing cell therapy research, reports Shabana Begum for The Straits Times. “Imagine providing the right living cells…to each patient as quickly and safely as possible,” explains Prof. Krystyn Van Vliet. "Delivering on that promise requires exciting changes in the way we understand, engineer, measure and select cells."
Diana Kwon highlights the research of Prof. Katharina Ribbeck in an article for Scientific American about the biological benefits of mucus. “I like to call [mucus] the unsung hero of the body — it’s something that has such powerful effects over our health,” says Ribbeck.
Broad Institute postdoctoral associate Joshua Weinstein has developed a DNA microscope that allows researchers to investigate the locations and identity of DNA molecules, reports Sharon Begley for STAT. “Weinstein has so far used it to image human cancer cell lines and plans to apply the technology to tumors and the immune cells that infiltrate them,” writes Begley, “which might one day guide immunotherapy.”
President Emerita Susan Hockfield discusses her new book, “The Age of Living Machines,” her work as a neuroscientist, and the future of science and technology during a curated lunch conversation with HUBweek and Boston.com. Hockfield explains that a revolution spurred by the convergence of biology with engineering will lead to new technologies built by biology.
In an excerpt from her new book published in The Wall Street Journal, President Emerita Susan Hockfield explores how the convergence between biology and engineering is driving the development of new tools to tackle pressing human problems. Hockfield writes that for these world-changing technologies to be realized requires “not only funding and institutional support but, more fundamentally, a commitment to collaboration among unlikely partners.”
President Emerita Susan Hockfield speaks with Jim Braude of WGBH’s Greater Boston about her book, “The Age of Living Machines.” “We are looking at a population of over 9.7 billion by 2050,” explains Hockfield. “We are not going to get there without war or epidemics or starvation if we don’t develop technologies that will allow us to provide energy, food, water, health and health care sustainably.”
MIT researchers have found that tracking specific changes in the number of chromosomes inside prostate cancer cells might help determine whether tumors should be treated, reports Robert Preidt for HealthDay News. “Besides giving new insights into how prostate tumors form and spread, the chromosomal data might someday be employed clinically to inform risk stratification and treatment decisions,” Preidt explains.